new england journal of medicine semaglutide Tirzepatide as Compared with for the Treatment Obesity: @NEJM 🥸 SURMOUNT-5 Trial: Wow! 😱 Summary 👇👇👇 Semaglutide: The Drug of Today

Description

[DOI] [PubMed] [Google Scholar] 55.Seufert J., Gallwitz B

requires clinical setting, higher cost, time-intensive

This is supported by a study showing that re-introduction of GLP-1Rs into the POMC neurons of GLP-1R knockout mice did not reinstate weight loss in lean animals, but partially restored weight loss (~50%) in obese animals (196)

IMPORTANT SAFETY INFORMATION Who should not take ONYDA XR

Zepbound (tirzepatide) is a medication approved by the Food and Drug Administration (FDA) to treat obesity and obstructive sleep apnea (OSA) in combination with a reduced-calorie diet and increased exercise